Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Cash Flow-to-Debt Ratio
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥45.11 Million could theoretically repay 0% of its total liabilities (CN¥700.20 Million) in one year. See 605016 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. across 10 annual periods. Also explore Shandong Bailong Chuangyuan Bio-Tech Co. equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
Year-by-year debt coverage analysis for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.. For market capitalisation and broader financial context, see Shandong Bailong Chuangyuan Bio-Tech Co. (605016) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥135.45 Million | CN¥475.19 Million | ▼ -68.3% |
| 2024 | 0.90x | CN¥300.89 Million | CN¥334.27 Million | ▲ +13.9% |
| 2023 | 0.79x | CN¥194.63 Million | CN¥246.35 Million | ▼ -33.0% |
| 2022 | 1.18x | CN¥149.82 Million | CN¥126.99 Million | ▼ -3.1% |
| 2021 | 1.22x | CN¥96.20 Million | CN¥79.05 Million | ▲ +44.7% |
| 2020 | 0.84x | CN¥121.82 Million | CN¥144.91 Million | ▲ +106.3% |
| 2019 | 0.41x | CN¥64.08 Million | CN¥157.28 Million | ▼ -50.6% |
| 2018 | 0.82x | CN¥89.12 Million | CN¥108.09 Million | ▲ +37.6% |
| 2017 | 0.60x | CN¥113.47 Million | CN¥189.38 Million | ▲ +168.3% |
| 2016 | 0.22x | CN¥60.10 Million | CN¥269.14 Million | — |